USPSTF Still Says Individualize Decision for Diet, Exercise Counseling

TUESDAY, July 26, 2022 (HealthDay News) -- The U.S Preventive Services Task Force (USPSTF) recommends that clinicians individualize the decision to offer counseling interventions for healthy diet and physical activity to their patients without cardiovascular disease (CVD) risk factors. These recommendations form the basis of a final recommendation statement published in the July 26 issue of the Journal of the American Medical Association.
Carrie D. Patnode, Ph.D., M.P.H., from Kaiser Permanente Evidence-based Practice Center in Portland, Oregon, and colleagues conducted a systematic review to synthesize the evidence on the benefits and harms of behavioral counseling interventions to promote a healthy diet and physical activity among adults without known CVD risk factors. Data were included from 113 randomized controlled trials (RCTs), with 129,993 participants. Three RCTs reported CVD-related outcomes. In one study, no difference was observed between the groups for any CVD outcome. In a combined analysis of two RCTs with 1,203 participants, there was a significant association of the intervention with nonfatal CVD events and fatal CVD events at four years (hazard ratios, 0.27 and 0.31, respectively). Small, statistically significant reductions were seen in continuous measures of blood pressure, low-density lipoprotein cholesterol level, and other outcomes for diet and physical activity behavioral counseling interventions versus control conditions at six months to 1.5 years of follow up.
Based on these findings, the USPSTF concludes that behavioral counseling interventions have a small net benefit on CVD risk in adults without CVD risk factors with moderate certainty (C statement). Clinicians should individualize the decision to offer or refer adults to behavioral counseling interventions to promote a healthy diet and physical activity.
"When determining which patients might benefit from counseling interventions, health care professionals should consider the patient's goals and motivations, activity, and ability," a task force member said in a statement.
Final Recommendation Statement
Related Posts
Intra-Articular Injection of Triamcinolone Beneficial in Hip Osteoarthritis
FRIDAY, April 8, 2022 (HealthDay News) -- For patients with hip osteoarthritis...
Early Effectiveness Assessed for Fourth Dose of BNT162b2 Vaccine
THURSDAY, April 21, 2022 (HealthDay News) -- A fourth dose of the BNT162b2...
Adaptation to Pharmacotherapy Does Not Up Smoking Cessation in Black Adults
TUESDAY, June 27, 2023 (HealthDay News) -- For Black adults who smoke,...
¿La deuda de los préstamos estudiantiles amenaza a la salud?
JUEVES, 5 de mayo de 2022 (HealthDay News) -- Mientras la administración de...
